Jan-07-25 09:45AM Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Growth Stock (Zacks) Dec-27-24 02:09PM Arcellx Stock Earns 82 Relative Strength Rating (Investor's Business Daily) Dec-24-24 03:23PM Neurocrine Biosciences Stock Sees RS Rating Upgrade (Investor's Business Daily)...
3 Zacks Trade Account Minimum $0 Fee $0.01 per share stock trades Open An Account Performance The fund has returned 0.50 percent over the past year, -2.33 percent over the past three years, 1.78 percent over the past five years, and 4.01 percent over the past decade. SEE MORE CPXFX ...
3 Zacks Trade Account Minimum $0 Fee $0.01 per share stock trades Open An Account Performance The fund has returned 10.55 percent over the past year, 2.27 percent over the past three years, 1.84 percent over the past five years, and 3.26 percent over the past decade. SEE MORE GICAX PE...